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Abstract of Thesis
Excitotoxicity can lead to increases in intracellular Na+ and Ca2+ concentrations via the
glutamatergic NMDA receptors, which can lead to cell death. Detailing the timedependent degradation of neuronal components in response to excitotoxic challenge may
help elucidate the sequence in which these signaling pathways are initiated and further,
associate these pathways with topographic cellular demise. Using organotypic
hippocampal slice culture technique, tissue from neonatal rat pups was exposed to
NMDA, APV, or co-exposed for 24, 72 or 120 hours. Fluorescent microscopy of
propidium iodide (PI) was used to evaluate neuronal membrane damage, changes in the
density of mature soma (NeuN) and NMDA NR2B subunits were measured using
immunohistochemical procedures. After 24 hours of exposure, the CA1 showed an
increased PI signal and a decrease in NeuN marker, indicating somatic injury occurs
shortly after excitotoxic challenge; these effects were blocked by co-administration of
APV. Also in the CA1, loss of NR2B subunits, heavily expressed in dendritic processes,
declined following 72 hours of exposure. Because somatic injury precedes loss of distal
NR2B subunits, it is possible that these events involve different mechanisms, findings
that may be relevant in the development of therapies to target neurodegeneration resulting
from excitotoxicity.
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Chapter One: Introduction

Excitotoxicity
Glutamate is the most abundant excitatory neurotransmitter found in the
mammalian central nervous system (CNS). The activation of glutamatergic receptors is a
crucial component in the proliferation, maintenance, and survival of neurons (Cooper et.
al., 2003; Hardingham & Bading, 2003).

However, when neurons are chronically

exposed to glutamate or exposed to excessive concentrations of the neurotransmitter, they
can become over stimulated, a condition defined by Olney as excitotoxicity (Choi, 1992;
Olney, 1986). Conditions suspected to involve glutamate induced excitotoxicity include
alcohol withdrawal (Prendergast et al., 2004), hypoxia-ischemia (Hertz 2008), epilepsy
(Olney et al, 1998), traumatic brain injury (TBI) (Hardingham & Bading, 2003) and
neurodegenerative diseases including Alzheimer’s (Albensi et al, 2004; Dong et al,
2009). Excitotoxicity can lead to the swelling of the cell, loss of cellular components via
activation of multiple signaling pathways including proteases, lipases, and the disruption
of mitochondrial membrane potential, all of which can culminate in cell death (Albensi,
2007; Choi et. al., 1987; Forder, 2009; Hardingham & Bading, 2003).

The following

research sought to detail the time-dependent degradation of neuronal components in
response to excitotoxic challenge in order to elucidate the sequence in which signaling
pathways are initiated and further, associate these pathways with topographic cellular
demise. This temporal and topographical mapping may identify crucial mechanisms in
the death cascade, which could then be targeted to halt the neurodegeneration that results
from excitotoxicity.
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Glutamate Mediated Calcium Activity
Cell Membrane Permeability to Calcium Ions
Glutamate induced excitotoxicity is a calcium (Ca2+) mediated event in which
intracellular Ca2+ concentrations increase to toxic levels from which the cell cannot
recover. There is a 10,000 fold Ca2+ concentration gradient across the plasma membrane,
with concentrations around 1-2 mM outside the cell and between 10-100 nM in the
cytoplasm (Marcoux & Choi 2002; Dingledine, et al., 1999). A key component in Ca2+
regulation is the plasma membrane calcium-ATPase (PMCA) (Choi, 1992; Dingledine, et
al., 1999). The PMCA transports Ca2+ from the cytosol into the extracellular space and is
regulated by several intracellular signaling pathways. However, because the PMCA is a
high affinity but low capacity transporter, its main role is to regulate Ca2+ concentration
when the cell is at rest. Following a depolarizing event, it is the fast acting Na+/Ca2+
exchanger that is capable of moving large amounts of Ca2+ into the extracellular space
(Feldman et al, 1996). The Na+/K+ -ATPase also works to reset Ca2+ levels, though more
indirectly. By resetting the cells membrane to its resting potential, thereby inhibiting
depolarization, the Na+/K+ -ATase makes the membrane less permeable to Ca2+ influx via
voltage-dependent calcium channels (VDCC) and N-methyl-D-aspartate (NMDA)
receptors (Cooper et. al., 2003). Gamma-aminobutyric acid (GABA) receptors also
contribute to stabilizing the plasma membrane and reducing Ca2+ permeability by
inhibiting depolarizing events (Cooper et. al., 2003).

The effects of Na+ coupled

glutamate transporters located on astrocytes also help protect the cell from excitotoxicity
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by removing glutamate from the synaptic cleft, thereby limiting its ability to affect
postsynaptic membrane calcium permeability (Marcoux & Choi 2002).

Intracellular Reaction to Increases in Calcium Ions
Once cytosolic Ca2+ levels have increased beyond physiological levels, the
endoplasmic reticulum (ER) and mitochondria, two major organelles critical to cellular
function, can become compromised. The ER is continually transporting cytosolic Ca2+
across its membrane by means of the smooth ER Ca2+ATP-ase (SERCA) to maintain a
100 fold higher Ca2+ concentration inside the ER than in the cytosol (Marcoux & Choi
2002). The ER membrane also has two ligand gated Ca2+ channels, inositol trisphosphate
(IP3) and ryanodine receptors, which mediate the release of Ca2+ stores from the ER.
The IP3 receptor is activated when bound by IP3, which is released in response to Gprotein coupled glutamate receptor activation. The ryanodine receptor is activated in
response to elevated intracellular Ca2+ concentrations (Marcoux & Choi 2002).
Activation of these receptors not only increases cytosolic Ca2+ concentrations, but can
also lead to ER stress. This stress can release ER membrane bound caspase-12, which in
turn can activate executioner caspases, which induce apoptosis (Dingledine, et al., 1999).
The mitochondria are also sensitive to disruptions in Ca2+ homeostasis. During
times of normal activity, mitochondrial Ca2+ concentrations are ~100nM (Dingledine, et
al., 1999). However, upon influx of Ca2+ (ie, activation of glutamatergic receptors)
mitochondria function as a buffer, rapidly moving ions down an electrochemical gradient
via a uniporter, into the mitochondria (Bernardi & Rasola 2007).

In addition,

mitochondria possess a Na+ /Ca2+ exchanger that functions bi-directionally in reaction to
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physiological or pathological conditions.

Despite these dynamic mechanisms,

mitochondria can become compromised under high intracellular Ca2+ concentrations and
mitochondrial permeability transition pores (mPTP) can develop, a topic reviewed by
Crompton (1999). The formation of these pores can lead to cell death by either necrosis
or apoptosis. mPTP can permanently disrupt mitochondrial homeostasis and therefore,
the synthesis of ATP. Once a cell can no longer generate ATP, overall cell homeostasis
is compromised and necrosis can ensue (Crompton 1999; Dingledine, et al., 1999).
mPTP formation can also allow the release of several apoptotic molecules, initiating
either caspase-dependent or -independent pathways. The former pathway is initiated with
cytochrome c (cyt c) release through mPTP; the latter is initiated by the release of
apoptosis-inducing factor (AIF) through mPTP (Crompton 1999; Dingledine, et al., 1999,
Renolleau et al, 2008).

Glutamate Receptors and Excitotoxicity
Glutamate receptors are referred to as excitatory amino acid transmitters (EAA)
and can be classified into two categories, metabotropic and ionotropic; both are involved
in glutamate mediated excitotoxicity. The metabotropic glutamate receptor (mGluR)
family is distinct from ionotropic EAA receptors in that they are linked to G proteins and
bring about intracellular changes via second messenger systems (Cooper et al, 2003;
Feldman et al, 1997). The mGluR family is divided into 3 groups and contains a total of
7 receptors subclasses. Only the mGluR1 and mGluR5 receptor subclasses, which belong
to Group I, have excitatory actions and are therefore the only mGluR receptors implicated
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in the excitotoxic pathway. These receptors are found on postsynaptic membranes and
are Gq protein coupled.
The mGluR(1,5) pathway is initiated when glutamate binding causes a
conformational change that results in the release of the Gq alpha subunit. As illustrated
by Albert and others (2002), this alpha subunit phosphorylates nearby phospholipase C,
which then cleaves membrane bound phosphatidylinositol 4,5-bisphosphate (PIP2) into
two second messengers, inositol trisphosphate (IP3) and diacylglycerol (DAG).

As

previously mentioned, the ER has IP3 gated Ca2+ channels on its membrane. When
bound, the channel opens to release Ca2+ filled vesicles into the cytoplasm.

DAG

combines with Ca2+ to form a membrane bound DAG/ Ca2+ complex that is able to
activate protein kinase C (PKC) (Albert et al, 2002). PKC acts to phosphorylate proteins
thereby changing membrane permeability to extracellular ions, including Ca2+.

In

addition to increasing the intracellular Ca2+ load, DAG is also cleaved to form
arachidonic acid (AA). AA can change membrane permeability, effect ion pumps, and
activate protein kinases.

The cleavage of AA initiates the inflammation pathway,

producing eiconsinoids such as prostaglandin and leukotrienes, which can also lead to
cell death (Marcoux & Choi, 2002).
There are three ionotropic EAA receptors, N-methyl-D-aspartate (NMDA), α–
amino-3hydroxy-5-methyl-4isoxazoleproponic acid (AMPA), and kainic acid (KA)
receptors (Mody, 1995); all three participate in producing glutamate mediated
excitotoxicity (Marcoux & Choi, 2002).

The receptors have three transmembrane

domains with the N terminus located extracellularly and an intracellular C terminus. All
receptors have been named for and can be pharmacologically distinguished by their
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preferred agonist. In fact, the receptors belonging to the AMPA and KA families are
difficult to distinguish from one another outside of pharmacological discrimination; this
is largely due to a high amount of heterogeneity within the two. Such is the case that
they are often referred to jointly as non-NMDA receptors. Both of these non-NMDA
receptors are voltage-independent, ligand-gated ion channels that mediate fast excitatory
synaptic transmission (Cooper et al, 2003; Feldman et al, 1997). When activated they
allow for the influx of extracellular Na+.

In addition, activation of these receptors

initiates a localized depolarization of the cellular membrane, a fact that is of functional
importance to NMDA receptor activity. The NMDA receptor is channel bound by
magnesium (Mg+) ions. This block is released upon membrane depolarization, which
physiologically follows AMPA receptor activation (Koch et al, 2004). Once the receptor
channel is unblocked and in the presence of glycine and glutamate, the ion pore allows
Ca2+ and Na+ to enter the cell, the latter in lesser amounts, as well as a minor efflux of
potassium (K+) (Cooper et al, 2003; Feldman et al, 1997).
The ionotropic EAA receptor mediated excitotoxic pathway has been
characterized as being composed of two components, swelling followed by cell
degeneration (Crews & Chandler, 1993; Olney, 1986). In this model the stages are
separated dependent upon time and ion involvement. Minutes after an initial glutamate
insult, excessive glutamatergic activation of AMPAR and KAR is believed to allow for
the influx of excessive amounts of Na+ followed by a passive influx of Cl- and water, all
combining to account for an increase in cellular volume (Maulucci-Gedde & Choi 1987).
However, this acute swelling is not always sufficient to produce cell death (Albensi 2007;
Choi 1992). In fact, death is often not observed until a period of hours following
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excitotoxic triggers, if at all. The movement of Ca2+ via NMDA receptor activation has
been implicated as the crucial component in the ultimate demise seen in association with
glutamate induced excitotoxic cell death.

Formation and Composition of the NMDA Receptor
As previously mentioned, the NMDA receptor is both ligand gated and voltagedependent. This dual activation is dependent upon both pre- and post-synaptic activity.
The voltage sensitive Mg+ block is removed by local depolarizations that occur in the
post-synaptic membrane, the ligand is provided by pre-synaptic release of glutamate.
Due to these unique properties, the NMDA receptor is referred to as a “coincidence
detector” (Köhr, 2006). It is this ability of the receptor that allows it to produce long
term potentiation (LTP) (Dong, 2009). The receptor is also unique among the glutamate
receptors in that, in humans, it requires two of its known subunits, the NR1 and NR2, in
its channel structure to be functional (McIlhinney et. al., 2003).

A third and less

frequently expressed subunit type, the NR3, is believed to form a tretrameric
NR1/NR2/NR3 complex (Paoletti & Neyton, 2007). All NMDA receptors require the coagonists glycine and glutamate to be bound at the NR1 and NR2 receptor subunits,
respectively, for maximal activation.

If dual binding occurs during a localized

depolarizing event, ion permeability changes and the channel pore will allow the entry of
Ca2+and Na+, and small amounts of K+ are allowed to exit the cell.
The NR1 subunit is encoded by a single gene that can be spliced to form 7
different variants. The exact number of subunits required to produce a functional channel
pore remains unclear, however, evidence supports either di-heteromeric (NR1/NR2A or
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NR1/NR2B) or tri-heteromeric (NR1/NR2A/NR2B) structures (Al-Hallaq et al, 2007).
Recent studies indicate that, in young rat hippocampi approximately two-thirds of NR2
containing NMDA receptors are of the NR1/NR2A or NR1/NR2B structure while one
third are NR1/NR2A/NR2B tri-heteromeric complexes (Al-Hallaq et al, 2007). The
NMDA receptor is complex, possessing many different recognition sites through which
its function can be modified. All NMDA receptors subunits contain large extracellular
region that consist of two domains, the N-terminus domain and the agonist-binding
domain (ABD), as well as an ion channel domain, which is contained within the cellular
membranes (for review see Arundine & Tymianski, 2004; and also Paoletti & Neyton,
2007). Non-competitive antagonists including MK-801, mematine, and ketamine, as well
as the endogenous Mg+ interact at the ion channel domain, the latter in a voltagedependent manner. As previously mentioned, activation of NMDA receptors require the
competitive co-gonists glycine (or D-serine) and glutamate. Glycine binds at the ABD of
NR1and NR3 subunits, while glutamate binds at NR2 subunit ABDs. The N-terminus of
the NR1 and NR2 subunits contain allosteric modulatory site for polyamines (Li et al,
2007) this site is also used by the competitive antagonist ifenprodil (NR2B selective).
The N-terminus of NR2 subunit also has an inhibitory site for endogenous Zn+ (NR2A
and NR2B).

Function and Regulation of the NR2B Receptor Subunit
The NMDA receptor is believed to be comprised of two obligatory NR1 subunits
and two regulatory NR2 subunits. The NR2 subunit has four variants (NR2A, -B, -C, and
-D), which are encoded by four different genes (Dingledine et al., 1999). The NR2A and
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NR2B di-heteromeric complexes are the most common expressed in the CNS (Mony et.
al., 2009; Yashiro & Philpot, 2008). The prenatal and early postnatal rat brain contains a
higher ratio of NR2B as compared to NR2A subunits. However, with development, this
ratio changes in both an activity-dependent and independent manner (for review see
Yashiro & Philpot, 2008; Hardingham, 2009). Activation of the NMDA receptor is
associated with increased expression of NR2A mRNA. Therefore, it is thought that when
the NMDA receptor is active, NR2A subunits are expressed and become inserted at the
synapse, changing the ratio of NR2B to NR2A subunits. Additionally, NR2B subunit
expression has also been shown to down regulate with development in an activityindependent manner (Hardingham, 2009).
The subunit composition of the NMDA receptor has direct implications toward its
channel kinetics (Erreger et al., 2005; Vicini et al., 1998), synaptic localization (Köhr,
2006), and protein binding partners (Hardingham et. al., 2002; Vanhoutte & Bading,
2003; Ivonov et al., 2006). Using recombinant NMDA receptors, Erreger and others
have shown that NR1/NR2A heteromers had faster gating (open/close) time than did
NR1/NR2B. However, NR1/NR2B heteromers had longer activation duration, therefore
greater total conductance of Ca2+. Although subunit composition is important to the
function of the NMDA receptor, another factor is the receptor location. NR2B containing
NMDA receptors are found in higher concentration in the extrasynaptic space than are
NR2A heteromers (for review see Köhr, 2006). It appears that both location and subunit
composition together indicate the intracellular signaling pathways that are activated by
the NMDA receptor. Several studies have suggested an opposing role for synaptic versus
extrasynaptic NMDA receptor activation. Synaptically located NR1A containing NMDA
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receptors have been shown to activate cAMP response element binding protein (CREB;
Hardingham et al., 2002) and, via CREB activation, brain-derived neurotrophic factor
(BDNF) gene expression (Vanhoutte & Bading 2003), as well as extracellular signalregulated kinases (ERK; Ivanov et al., 2009). In contrast, activation of the extrasynaptic
NR2B subunit appears to shut off CREB activation and thereby decrease the expression
of BDNF. Similarly, activation of extrasynaptic NR2B containing NMDA receptors
triggers the inactivation of ERK activity.

Lastly, using the Xenopus oocyte as an

expression system, Williams (1994) found that the NR2B containing NMDA receptor is
stimulatory when both active and bound by the polyamine spermine, a characteristic not
found in the NR2A heteromer.
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Chapter Two: The Role of Excitotoxicity in Disease

Excitotoxicity and EtOH
The affects of EtOH on the glutamatergic system are complex and still being
defined. It is believed that EtOH acts as an allosteric modulator at NMDA receptors.
Acutely, EtOH acts to inhibit NMDA receptor activity; however, chronic EtOH exposure
enhances activity at the receptor (for review see Kumari and Ticku, 2000). In response to
acute inhibition to EtOH, the cell is believed to upregulate NMDA receptors in order to
maintain homeostatic intracellular Ca+ levels. When EtOH, and therefore inhibition, is
removed during withdrawal, the increased abundance of NMDA receptors can be
activated to increase intracellular Ca+ to cytotoxic levels.

As previously discussed,

NR2B containing NMDA receptors have a greater capacity for Ca2+ conductance than
other NMDA receptor subunit compositions. In addition to this, the polyamine binding
site on the N-terminus of the NR2B that can potentiate NMDA receptor activity; EtOH
exposure increases the amount of polyamines present in the brain. Therefore, increased
polyamines occurring in the presence of NR2B subunits can additively contribute to rises
in intracellular Ca2+. Finally, data indicate extrasynaptically located NR2B subunits can
oppose some neurotrophic effects generated by cells in response to injury.

Excitotoxicity and Epileptic Seizures
Epilepsy is a diverse brain disorder that has been classified into over 40 distinct
types based on several different factors including age of onset, characteristic symptoms
and signs, seizure types, cause, and electroencephalographic pattern (for review see
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McNamara, 1999). Genetics play an important role in epilepsy, with more than a dozen
gene mutations identified as being linked to epileptic phenotypes.
In 1983, Olney and colleagues replicated both status epilepticus and epileptic
seizure activity by electrically stimulating the perforant pathway of the hippocampus, the
structures major route for receiving information, for either 2 hours continuously or
intermittently over a 24 hour period. The group found neuronal degeneration, both
somatic and dendritic, in the pyramidal cells of the CA3 and CA1 as well as evidence of
neuron induced glial damage in the same areas. These changes were attributed to over
activation of the glutamatergic neurons of the hippocampus, which produced
excitotoxicity. Over activation of NMDA receptors during seizure activity can lead to the
activation of proteases, damage to DNA, the creation of mPTP and subsequent activation
of apoptotic cascades, all which can lead to cell death (reviewed by Fujikawa, 2005).

Excitotoxicity and Traumatic Brian Injury
Traumatic brain injury (TBI) can be classified into two categories (1) primary,
which occurs at the time of injury and includes lacerations, fractures of the skull,
hemorrhage, and surface contusions of the brain and (2) secondary, which can be initiated
at the moment of injury but which develops over a subsequent period of time (Cater et al,
2007; Graham et al, 2000).

Secondary injuries include edema, infection, ischemic

insults, oxidative stress, and changes in endogenous neurotransmitters, including
glutamate (Yi, et al., 2006).

As previously stated, glutamate is the most abundant

neurotransmitter in the human CNS.

As would stand to reason, there are also an

abundance of glutamatergic neurons in the CNS, as well as astrocytes, which transport
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and breakdown glutamate. When these neurons and astrocytes become damaged during
either primary or secondary insult presented by TBI, their contents, including glutamate,
can spill into the extracellular milieu.

The rise in glutamate activity can further

exacerbate the TBI by producing and excitotoxic environment. Therapeutics are directed
at mediating these secondary effects includes targeting those mechanisms common to
NMDA mediated excitotoxicity.
Excitotoxicity and Hypoxia-Ischemia
Hypoxic-ischemic (HI) conditions, when the brain is deprived of oxygen and
glucose, can result in extracellular glutamate concentrations that deviate from
homeostatic levels due in part to the rupture of glutamatergic neurons. When these
neurons rupture, the neurtotransmitters they contain, including glutamate, are spilled into
the extracellular milieu, where they are free to affect neighboring neurons (Hardingham
& Bading, 2003). Also a factor in HI damage is the injury sustained by astrocytes, which
normally function to remove glutamate from the synaptic space, thus allowing prolonged
post synaptic stimulation (Hertz, 2008).

The NR2B NMDA receptor subunit, in

particular, has been implicated in contributing to elevated intracellular Ca2+. Reasons for
this may due to the activation by the NR2B containing NMDA receptor complex by
polyamines, which are expressed following brain injury (Li et al, 2007). However, the
rise in intracellular Ca2+ cannot solely be contributed to increased extracellular glutamate
levels. This was elucidated by Mitani (1993) in experiments using hippocampal slices
from gerbils exposed to ischemic-like conditions (exposure to medium absent of glucose
and oxygen). The hippocampal tissue showed a significant rise in intracellular Ca2+
levels both in the presence and absence of media containing glutamate. This intracellular
18

release of Ca2+ is thought to be attributed to activation of ER receptors, which release
Ca2+ stores from the ER and to the dysregulation of mitochondria.

Mitochondrial

dysregulation can lead to increased use but decreased production of ATP, which can
break down the mitochondrial membrane, thereby releasing Ca2+ stores.

Rises in

cytosolic Ca2+ via ER and mitochondria release can further cause the formation of mPTP
and subsequent release of cyt c,

as well as activation of AIF, all culminating in

excitotoxic cell death (for review see Arundine &Tianski, 2004).

Excitotoxicity and Alzheimer’s Disease
The first indications that implicated the glutamatergic system in Alzheimer’s
disease (AD) were proposed by Greenamyre et al. in 1988. Upon autopsy of individuals
who had died with AD, the group found a decrease in available glutamate binding sites
that resulted in reduced glutamate binding in the cortical regions of the brain as compared
to individuals who had no neurological disease. Based upon these and other similar
findings, the glutamatergic hypothesis of dementia was proposed (Albensi et al, 2004).
Molecular hallmarks of AD include extracellular β-amyloid peptide (Aβ) plaque deposits
and intracellular neurofibrillary tangles (NFT) in the hippocampus and other brain
regions necessary to cognitive and memory function (as reviewed by Dong et al, 2009).
It is suspected that Aβ plaques either sensitize or activate NMDA receptors (Koch et al,
2004) and lead to widespread apoptosis in the pyramidal cells of the CA1 (MiguelHidalgo et al, 2002). The alteration of NMDA receptors allow their activation at μM
concentrations of glutamate as opposed to the mM concentrations required under
physiological conditions, producing excitotoxicity (Dong et al, 2009).
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In the

hippocampus, neuropathic activity of NMDA receptors leads to memory and cognitive
deficits because constant activation prevents the receptors from being “co-incidence
detectors”, thus preventing LTP (Dong et al, 2009). Further evidence implicating the
NMDA receptor in AD is the action of the therapeutic drug memantine. Memantine is
low affinity blocker of the NMDA channel and works to “re-regulate” NMDA receptors
that have been sensitized by Aβ plaques (Koch et al, 2004). The goals of therapeutic
drugs that target NMDA receptors being developed to treat AD such as memantine, are to
prevent excitotoxicity and the downstream intracellular cascades that lead to
mitochondrial dysfunction, caspase activation, and cell death.
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Chapter 3: Summary and Hypothesis

Summary
Because Ca2+ has the ability to activate many different cell signaling pathways,
regulation of this cation is crucial to cell survival and proper neuronal function.
Excessive glutamatergic activity can bring about the disruption of Ca2+ homeostasis; this
disruption can lead to excitotoxicity, a condition that can be fatal to cells. Each EAA
receptor represents a different pathway through which cytosolic Ca2+ levels can become
elevated, thereby increasing the possibility of cell death. However, the NMDA receptor
is unique in its ability to produce excitotoxicity. Because it contains a dense population
of NMDA receptors and is therefore exquisitely susceptible excitotoxicity, the
hippocampus is an ideal structure in which to study the phenomenon.

This brain

structure is composed of three subregions, the granule cells of the DG and the pyramidal
cells of the CA1 and CA3, of these, the CA1 has been shown most susceptible to
excitotoxicity (Butler et al., 2009). It has been suggested that this regional difference can
be attributed to the larger population of mature neurons and dendritic processes found in
the CA1. In addition, the pyramidal cells of this subregion contain more NR1/NR2B
heteromers than are found in other subregions, a configuration that confers greater
conductance of Ca2+ across the membrane and a characteristic that is potentiated in the
presence of polyamines.
The proposed studies will examine the time-dependence of neuronal nuclear
degradation (ie. PI fluorescence, NeuN staining) and loss of NR2B subunit density,
following an excitotoxic insult to provide a better understanding of the topographical
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nature of neuronal death following NMDA receptor activation. The topographical
"mapping" of neuronal injury or death following NMDA receptor activation is important
as it may elucidate the specific cellular mechanisms that precipitate cellular demise.
Identification of these mechanisms is crucial to the development of novel therapeutic
strategies to be used in the treatment of disease states that are associated with excitotoxic
insult.
Hypotheses
Experiment (1) NMDA, a NMDA receptor agonist, will be administered to
hippocampal slices in levels sufficient to produce excitotoxicity; a NMDA receptor
antagonist will be co-administered to an experimental group to as a proof of NMDA
receptor mediated cell death. After 24, 72, or 120 hours, granule cells of the DG and the
pyramidal cells of the CA1 and CA3 regions of the hippocampal formation will be
measured to assess cell death (i.e. propidium iodide (PI) fluorescence). Experiment (2)
following NMDA administration, immunohistochemical techniques will be used to assess
loss of mature neurons (i.e. NeuN staining) over 24, 72, or 120 hour periods. Experiment
(3) procedures used in experiment 2 will be replicated using NR2B staining antibodies to
assess loss of this subunit over the same time course. It is hypothesized that, in reaction
to NMDA: (1) cell death will be region dependent, with highest total loss occurring in the
pyramidal cells of the CA1 hippocampal subregion (2) this cell death will be time
dependent with the greatest cellular loss occurring after 24 hours (3) the total loss of
mature neurons (NeuN staining) will be most substantial in the pyramidal cells of the
CA1 hippocampal region (4) this loss of mature neurons will be significant after 24 hours
and greatest after 120 hours (5) the total loss of NR2B subunits will be highest in the
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pyramidal cells of the CA1 hippocampal region (6) this loss of NR2B subunits will be
significant after 24 hours and greatest after 120 hours.
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Chapter 4: Methods

Organotypic Hippocampal Slice Culture Preparation
Organotypic hippocampal slices will be obtained from 8-10 day old male and
female Sprague Dawley rat pups (Harlan Laboratories, Indianapolis, IN, USA). Pups will
be decapitated; the whole brain extracted and placed in chilled dissecting medium
comprised of Minimum Essential Medium containing Hanks’ salts and L-glutamine
(MEM; Gibco, Gaithersburg, MD, USA), 25 mM HEPES (Sigma-Aldrich Co., St. Louis,
MO, USA), and 50 µM Penicillin/Streptomycin (Gibco). The bilateral hippocampi will
be removed, placed in culture medium composed of dissecting medium with the addition
of: 36 mM glucose (Fisher Scientific, USA), 25% (v/v) Hanks’ balanced salt solution
(Gibco), 25% heat-inactivated horse serum (Sigma-Aldrich Co.), and 0.05% Penicillin/
Streptomycin. Under a dissecting microscope, loose and extra tissue will be removed.
Each hippocampus will be coronally sectioned into 200µm slices using the McIllwain
Tissue Chopper (Mickle Laboratory Engineering Co. Ltd., Gomshall, UK), yielding
approximately 12 slices (approximately 24 per animal), and placed into fresh culture
medium. Slices will be sorted under a dissecting microscope to remove damaged or
partially sectioned specimens. Using transfer pipettes, intact slices will be placed three
per well onto porous Teflon membrane inserts (Millicell-CM 0.4 μm; Millipore,
Marlborough, MA) that had been incubated in 1 ml of culture media for a period of at
least one hour. Excess culture media will be aspirated from the top of the membrane.
Plates will be comprised of 6 wells and will yield 18 slices per plate. After plating, slices
will remain in an incubator exposed to an atmosphere of 5% carbon dioxide 95% air and
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at constant temperature of 37⁰C for 5 days to allow the tissue to adhere to the membrane
and to stabilize the slices. This method was adapted from Stoppini et al., 1991. Care of
all animals will be performed in accordance with the guidelines of the National Institutes
of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023), as well as with the University of Kentucky’s Institutional Animal Care and Use
Committee. All experiments discussed will be replicated using different rat litters.

NMDA Stimulated Excitotoxicity
Excitotoxicity will be induced in cell cultures using NMDA, a selective agonist of
the NMDA receptor. NMDA will be chosen over glutamate, the endogenous NMDA
receptor ligand, to isolate NMDA receptor activation from other EAA receptors. DL-2Amino-5-phosphonopentanoic acid (APV), a selective NMDA receptor antagonist, will
be used to block the activation of the NMDA receptor. After 5 days in vitro (DIV), inserts
will be transferred into plates filled with 1 ml of fresh, pre-incubated media that will
contain 3.74 μM propidium iodide (PI) (Sigma-Aldrich) and, in addition, will contain
either 50 μM APV (Sigma-Aldrich), 20μM NMDA (Sigma-Aldrich), or 20 μM NMDA
and 50 μM APV (NMDA/APV). Cultures will be returned to the incubator and allowed
to rest for a period of 24, 72, or 120 hours. After each of these time points, plates will be
removed from the incubator and assessed for cell cytotoxicity as described below.

Propidium Iodide Uptake in Treated Cultures
Fluorescent microscopy of propidium iodide (PI) will be used to assess levels of
cell cytotoxicity incurred by cell cultures after time dependent exposure to NMDA and/or
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APV. Membrane impermeable PI binds to DNA and RNA once the cellular membrane
becomes compromised. Once bound to these nucleic acids, the fluorescence of PI is
enhanced 20-30 fold (Arndt-Jovin & Jovin, 1989). This altered wavelength allows for
non-bound concentrations of PI to be excluded from analysis.

The use of this staining

technique has been significantly and reliably correlated with other measures of cell death
and cytotoxicity (for review, see Zimmer et al., 2000). Uptake of PI will be imaged with
SPOT Advanced version 4.0.2 software for Windows (W. Nuhsbaum Inc., McHenry,IL)
using a 5x objective on a Leica DMIRB microscope (W. Nuhsbaum IL) fitted for
fluorescence detection (mercury-arc lamp) and connected to a personal computer via a
SPOT 7.2 color mosaic camera (W. Nuhsbaum Inc.). When bound to nucleic acids, the
peak excitation wavelength of PI is 535 nm, with emission maximum of 617nm. The
wavelength will be excited to between 510-560 nm using a rhodamine band-pass filter.
The intensity of PI within each culture will be determined by densitometry using Image J
1.29x (National Institutes of Health, Bethesda, MD). Three cell layer regions of the
hippocampal formation were analyzed for cytotoxicity, the granule cells of the dentate
gyrus (DG) and the pyramidal cells of the cornu Ammonis-3 (CA3) and cornu Ammonis1 (CA1). The visual field containing each sub-region of interest will be measured; a
background measure will be also taken for each tissue slice analyzed.

To reduce

environmental variations between slices, the background value will be subtracted from
each sub-region value. This will result in an intensity measure for each sub-region of
each slice, 9 measures per well, 54 per plate. These values will be recalculated, dividing
by intensity values for a control plate, to express the value as a percent of control.
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Immunoreactivity of Neuron Specific Nuclear Protein and NMDA NR2B Subunits
Immunohistochemical labeling using monoclonal antibodies will be used to
measure the density of both mature neurons and NMDA NR2B subunits. Neuron specific
nuclear protein (NeuN) primary antibody will be used to identify mature neurons in the
granule cells of the DG and the pyramidal cells of the CA1 and CA3 of the hippocampus.
NeuN antibody recognizes the neuron-specific NeuN protein, which is found in the CNS
of all vertebrates (Mullen, 1992). NeuN is first evident in neurons shortly after they
become post-mitotic and/or shortly after differentiation (Mullen, 1992).

Therefore,

strong staining of NeuN indicates the presence of mature cells. The monoclonal antiNR2B primary antibody will be used to measure the density of NMDA NR2B subunits in
the same hippocampal regions.

Mouse or rabbit fluorescein isothiocyanate (FITC)-

conjugated secondary antibody will be used with NeuN and NR2B antibodies,
respectively.
Following PI analysis discussed previously, culture slices will be removed from
culture medium for fixation with 10% formalin, during this procedure slices will be
preserved on previously plated inserts. Inserts will be immersed in wells containing 1 ml
of formalin, an additional 1 ml of formalin will be applied to the top of the insert; inserts
will be allowed to rest in formalin for 30 minutes. Inserts will be removed from formalin
plate and will be placed in plates containing 1ml of 1x PBS, with 1 ml 1x PBS slowly
added to the top of the insert, then drained, a procedure termed washing. This wash will
be performed twice before inserts will be transferred to plates containing 1 ml of 1x PBS
and stored at 4°C until immunohistochemistry will be conducted.
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Prior to

immunohistochemistry, slices will be placed in a plate containing 1ml buffer consisting
of 1x PBS, 0.005% bovine serum albumin, and 0.1% Triton-X (Sigma-Aldrich), with 1
ml of buffer slowly added to the top of insert. Cultures will be allowed to rest for 45
minutes to permeabilize cell membranes. Following this incubation period, cultures will
be transferred into fresh plates containing 1 ml of1 x PBS, 1 ml of buffer and mouse antiNeuN monoclonal primary antibody (1:200; Chemicon, Temecula, CA) or rabbit antiNR2B monoclonal primary antibody (1:500; Chemicon, Temecula, CA) will be added
slowly to top of inserts; cultures will be stored for 24 hrs at 4°C. Following this
incubation period, cultures will be washed twice in 1x PBS and placed into fresh culture
plates containing 1 ml of 1 x PBS, 1 ml of buffer and anti-mouse (NeuN; 1:200) or antirabbit (NR2B; 1:200) fluorescein isothiocyanate (FITC)-conjugated secondary antibody
(Sigma-Aldrich) will be slowly added to top of inserts previously treated with NeuN,
those previously treated with NR2B will receive the same treatment but with anti-rabbit
FITC (1:200; Sigma-Aldrich). Plates will be stored at 4°C for 24 hours before fluorescent
images will be taken. FITC fluorescence will be elicited using a band-pass filter that
excites wavelengths of approximately 495 nm (emission wavelength = 520 nm). Images
will be taken using a 5× objective lens, as described previously.
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Chapter 5: Results
Statistical Analysis
Two-way ANOVA (treatment x region) was conducted to investigate the validity
of the a priori hypothesis regarding regional differences in reaction to exposure to
NMDA. Three-way ANOVA (time x treatment x sex) was conducted to investigate
differences within the subregions of the hippocampus.

A reduced design, two-way

ANOVA (treatment x time), was used if no effect of sex was detected by the omnibus
analysis. Following ANOVA analyses, the Fisher’s LSD post-hoc test was interpreted
when appropriate; significance level was set at P < 0.05.

All analyses are of a between

subjects design and all data is expressed as percent control for ease of interpretation.
Experiments were replicated a minimum of two times, all data represent tissue sampled
from a minimum of two litters. Tissue from both male and female animals was used.

Results
Propidium Iodide Uptake in Treated Cultures
Densitometric analysis of cell toxicity as measured by PI fluorescence was
evaluated in the pyramidal cell layers of the CA1 and CA3 and the granule cell layer of
the DG. To test the a priori hypothesis that exposure to 20 μM NMDA would produce
greater toxicity in the CA1 as compared to the CA3 and DG, a two-way ANOVA
(treatment x region) was performed.

A significant interaction was found (F(6,

1262)=25.508; P<0.001). As predicted, increased PI fluorescence was largest in the CA1
(277.545, ±14.489) as compared to the CA3 (211.001, ±17.37) and the DG (132.505, ±
5.759; Fig. 1).

Further analysis was conducted to explore differences within the
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subregions of the hippocampus. A three-way ANOVA (time x treatment x sex) was
conducted in each region (CA1, CA3, DG), which revealed no significant sex effect in
any region. A reduced, two-way ANOVA (treatment x time), revealed a significant
interaction within the CA1 (F(6,420)= 16.728, P < 0.001). NMDA treatment resulted in
significant toxicity on days one (319.41, ±32.38), three (338.34, ±14.63), and five
(173.62, ±12.63; Figure 2A) as compared to controls. These data are consistent with the
previously stated hypothesis, which predicted the greatest toxicity would occur on day
one. As compared to control values, NMDA/APV was not associated with significant
increases in PI fluorescence on days three and five but did reach significance on day one
(138.78, ±8.28; Fig. 2A).

However, co-administration of NMDA/APV did reduce

NMDA induced damage at all time points. APV exposure resulted in no significant
change in PI fluorescence as compared to controls at any time point (Table 1).

In the

CA3, two-way ANOVA (treatment x time) revealed a significant interaction (F(6,420) =
19.345, P < 0.001). APV and NMDA/APV treatment groups did not differ significantly
from control values at any time point (Table 1, Fig. 1B).

However, NMDA treatment

produced significant toxicity as compared to controls, reaching maximal effect on day
one (345.77, ±42.29), which diminished on day three (135.38, ±6.90), from which there
was no significant change on day five (148.01, ±6.84, P<0.508); Figure 1B). Within the
DG, two-way ANOVA (treatment x time) revealed no significant interaction (Figure 1C).
However, a main effect for treatment (F(3, 420)=15.956, P<0.001) was found, with
NMDA (132.33, ±3.423) and NMDA/APV (113.512, ±3.439) treatments associated with
significantly higher PI fluorescence as compared to control values. However, APV coadministration was effective at reducing NMDA induced damage.
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Figure 1: Effects of exposure to 20µM NMDA on PI fluorescence in the pyramidal cells
of the CA1 as compared to the pyramidal cells of the CA3 and the granule cells of the
DG (* p< .05 vs. CA1).
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Figure 2A-C: Time dependent effects of exposure to 20µM NMDA or 20µM NMDA +
50µM APV on PI fluorescence in the pyramidal cells of the CA1 (A), CA3(B), and the
granule cells of the DG (C). (* p< .05 vs. control; ** p< .05 vs. Day 1; # main effect of
treatment p<.05).
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Immunoreactivity of Neuron Specific Nuclear Protein
Mature neuron density, as indicated by NeuN immunoreactivity, was analyzed using
densitometry for the pyramidal cell layers of the CA3 and CA1 and the granule cell layer
of the DG. To test the a priori hypothesis that exposure to 20 μM NMDA would produce
greater reductions in the density of mature neurons in the CA1 as compared to the CA3
and DG, a two-way ANOVA (treatment x region) was performed, a significant
interaction was found (F(6, 2075)=14.807; P<0.001). As predicted, reduction in NeuN
reactivity was largest in the CA1 (52.57, ±1.42) as compared to the CA3 (76.36, ±1.80)
and DG (76.37, ±1.37).
regions (Fig. 3).

No significant difference was found between the latter two

Further analysis was conducted to explore differences within the

subregions of the hippocampus. A three-way ANOVA (time x treatment x sex) was
conducted in each region (CA1, CA3, DG), which revealed no significant sex effect. A
reduced design, two-way ANOVA (treatment x time), revealed a significant interaction
within the CA1 (F(6, 691)= 6.13, P<0.001). In this region, NMDA treatment was shown
to significantly reduce the density of mature neurons relative to controls at all time
points.

Supporting the hypothesis regarding time-dependent loss in this region,

significant declines in the density of mature neurons was observed at day one (62.04,
±2.67). Contrary to the hypothesis, which stated that the largest decline would be evident
at day five, there was a decline at day three (47.82, ±2.84), from which there was no
significant change on day five (47.95, ±2.58; Fig. 3A).

NMDA/APV treatment group

values were significantly different from control values, with an increase in NeuN
immunofluorescence at day five (116.65, ±4.68; Fig. 3A), illustrating that APV blocked
NMDA mediated reduction in mature neurons. No significant effect was associated with
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APV treatment in the CA1 at any time point (Table 2). Two-way ANOVA (treatment x
time) in the CA3 revealed no significant interaction, however, there was a main effect of
treatment (F(3, 691)=46.451, P<0.001). Significant treatment effects were seen upon
exposure to NMDA (76.252, ±1.884) and APV (108.83, ±2.93; Fig. 3B; Table 2). Twoway ANOVA (treatment x time) in the DG also revealed no significant interaction.
However, there was a main effect of time (F(2,691)=7.44, P<0.001) and treatment
(F(3,691)=56.625, P<0.001). NMDA treatment (73.346 ±1.423) produced significantly
lower NeuN immunofluorescence as compared to control group in this region (Fig. 3C).
Imunoreactivity of NMDAR2B Subunits
Density of NMDAR2B subunits, as indicated by NR2B immunoreactivity, was analyzed
using densitometry in the pyramidal cell layers of the CA1 and CA3 and the granule cell
layer of the DG. The a priori hypothesis, which stated that exposure to 20 μM NMDA
would result in a
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Figure 3: Effects of exposure to 20µM NMDA on NeuN immunofluorescence in the
pyramidal cells of the CA1 as compared to the pyramidal cells of the CA3 and the
granule cells of the DG (* p< .05 vs. CA1).
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Figure 4A-C: Time dependent effects of exposure to 20µM NMDA or 20µM NMDA +
50µM APV on NeuN protein immunofluorescence in the pyramidal cells of the CA1 (A),
CA3(B), and the granule cells of the DG (C). ( * p< .05 vs. control; ** p< .05 vs. Day 1,
# main effect of treatment p<.05, + main effect of time p<.05).

greater reduction of NR2B subunit protein in the CA1 as compared to the CA3 and DG,
was tested by conducting a two-way ANOVA (treatment x region).

A significant

interaction was found (F(6, 2183)=8.881, P,0.001), with a greater loss of NR2B protein
occurring in response to NMDA exposure in the CA1 (83.699, ± 1.106) as compared to
CA3 (93.665, ± 1.106) or DG (92.816, ± 1.106; Fig. 5), consistent with the hypothesis.
Analysis exploring differences within the subregions of the hippocampus was initially
conducted using a three-way ANOVA (time x treatment x sex), for each region. No
significant sex effect was found in any region, therefore, a reduced design, two-way
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ANOVA (time x treatment), was used for subsequent analysis. Within the CA1, two-way
ANOVA (treatment x time) revealed a significant interaction (F(6, 727)= 11.24,
P<0.001). NMDA treatment significantly reduced NR2B density on days three (73.885,
± 1.840) and five (77.184, ±1.861; Fig. 6A). NMDA/APV treated group did not differ
significantly from control group any time point (Fig. 6A), verifying that APV was
effective in this area of mediating NMDA induced loss of NR2B subunits.

APV

treatment significantly altered NR2B subunit density on day one (112.38, ±2.86) and day
five (90.96, ±2.93; Table 3). Two-way ANOVA (treatment x time) revealed a significant
interaction within the CA3 hippocampal region (F(6,727)=7.18, P<0.001).

NMDA

treatment significantly changed NR2B subunit density on days one (105.48, ± 1.792),
three (88.90, ±1.812), and five (86.17, ±1.834; Fig. 6B). Treatment with NMDA/APV
was shown to significantly reduce NR2B subunit density on day three (90.96, ±2.817;
Fig. 6B). APV resulted in altered subunit levels on days three (89.01, ±2.27) and five
(89.01, ±2.76; Table 3). Two-way ANOVA (treatment x time) conducted in the DG
revealed a significant interaction (F(6, 727)=5,820, P<0.001). NMDA exposure was
shown to reduce NR2B subunit protein on day three (84.995, ±1.725) and day five
(89.866, ±1.745). Additionally, exposure to NMDA/APV significantly reduced NR2B
subunit protein on day three (88.773, ± 2.681). Treatment with APV was associated with
decreased NR2B immunoreactivity on day three (89.01, ± 2.72) and day five (89.01, ±
2.76).
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Figure 5: Effects of exposure to 20µM NMDA or 20µM NMDA + 50µM APV on NR2B
protein immunofluorescence in the pyramidal cells of the CA1 (A), CA3(B), and the
granule cells of the DG (C) ( * p< .05 vs. CA1).
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Figure 6 A-C: Effects of exposure to 20µM NMDA on NR2B immunofluorescence in the
pyramidal cells of the CA1 as compared to the pyramidal cells of the CA3 and the
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vs. Day 1).
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Table 1: PI uptake in response to 50 μM APV treatment. Values expressed as percent control.
(p< .05 vs. control, # indicates main effect of treatment)

1 Day

Treatment Period
3 Days

5 Days

98.78 ± 2.90

122.3 ± 4.92

Subregion
CA1

100.06 ± 5.06

CA3

98.03 ± 4.11

#

101.47 ± 4.77

DG

106.5 ± 3.65

109.06 ± 6.10

#

109.28 ± 4.05#
108.7 ± 4.11

Table 2: NeuN immunoreactivity in response to 50 μM APV treatment. Values expressed as
percent control. (* p< .05 vs. control)

1 Day

Treatment Period
3 Days

5 Days

CA1

102.45 ± 4.85

100.726 ±5.46

92.637 ± 5.31

CA3

108.81 ± 6.05

102.749 ± 6.46

114.93 ± 6.34

DG

108.86 ± 5.91

94.716 ± 4.45

99.69 ± 2.86

Subregion

Table 3: NMDA NR2B subunit immunoreactivity in response to 50 μM APV treatment. Values
expressed as percent control. (* p< .05 vs. control)

1 Day

Treatment Period
3 Days

5 Days

CA1

112.38 ± 2.41*

97.76 ± 2.55

90.96 ± 2.44*

CA3

102.91 ± 2.22

94.57 ± 2.21

83.55 ± 4.32*

DG

101.81 ±1.99

89.01 ± 2.47 *

89.01 ± 2.20*

Subregion
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Chapter 6: Discussion
Glutamate mediated activity is a crucial component in the proliferation,
maintenance, and survival of neurons (Cooper et. al., 2003; Hardingham & Bading,
2003). This is due in part to its ability to provide much needed calcium Ca2+ to the
intracellular environment.

At physiological levels, intracellular Ca2+ is vital to the

phosphorylation and synthesis of proteins, cellular communication, and gene expression.
However, overexposure to glutamate or exposure to excessive concentrations of the
neurotransmitter, can allow intracellular Ca2+ to exceed physiological levels, a condition
defined by Olney as excitotoxicity (Choi, 1992; Olney, 1986). Pathological intracellular
Ca2+ concentrations can lead to the loss of cellular components via activation of multiple
signaling pathways, proteases, lipases, as well as to the disruption of mitochondrial
membrane potential, all of which can culminate in cell death (Albensi, 2007; Choi et. al.,
1987; Forder, 2009; Hardingham & Bading, 2003). Due to its crucial role in cell viability
there are several mechanisms in place dedicated to maintaining Ca2+ homeostasis. These
include the PMCA transporter and Na+/Ca2+ exchanger, which both work to remove Ca2+
from the cytosol (Choi, 1992; Dingledine et al., 1999). Additionally, the Na+/Ca2+
exchanger works to reset resting membrane potential, thereby limiting activation of
voltage dependent calcium channels and NMDA receptors (Choi, 1992; Dingledine et al.,
1999). The family of glutamatergic receptors is also important to Ca2+ homeostasis
(Cooper et al. 2003). These receptors can change intracellular Ca2+ concentrations either
directly, as with the previously mentioned NMDA receptor, or indirectly, as with the
mGluR and AMPA/KA receptors. mGluRs are capable of disrupting Ca2+ homeostasis by
activating IP3, an agonist capable of releasing intracellular stores of Ca2+. Additionally,
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because antagonizing these receptors dampens NMDA activity, the mGluRs are
suspected to interact with the intracellular NMDA receptor domain to modulate activity
(Harris, et al., 2002). Activation of the NMDA receptor directly changes membrane
permeability by opening a membrane channel pore, which allows the entry of Ca2+ as
well as Na+ (Cooper et al. 2003). Physiological activation of the NMDA receptor is
integral to learning and the formation of memories. However, pathological activation of
this receptor is sufficient to bring about excitotoxicity; such is the case that its activation
is dependent upon two events occurring simultaneously. First, the receptor must be
bound by both glycine and glutamate and, while bound, a localized membrane
depolarization, which removes Mg+ from the receptor channel, must also occur.
Depolarization of the membrane is carried out by glutamatergic AMPA/KA receptors and
is opposed by GABA receptors; both are co-localized with NMDA receptors.

The

receptors and exchangers discussed here are all crucial to maintaining Ca2+ homeostasis.
However, once homeostasis is disrupted, they are also the means by which rises in
cytosolic Ca2+ concentrations occur. Due to its ability to contribute to an excitotoxic
intracellular environment, the NMDA receptor has been the focus of numerous
investigations, including the current research.
Once NMDA receptors are activated, ionic membrane permeability is determined
by the stoichiometry of the receptor, with NR2B containing NMDA receptors able to
conduct the greatest concentrations of Ca2+ due to longer channel opening time (Erreger
et al., 2005). Additionally, the NR2B receptor is unique among the receptor subunit
types in its excitatory reaction to polyamines.

Polyamines are expressed during

excitotoxic events such as alcohol withdrawal and TBI (Williams, 1994). This unique
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consequence increases the ability of the NR2B subunit to confer Ca2+ across the
membrane. Further, recent evidence indicates that NR2B containing NMDA receptors
that are located extrasynaptically may inhibit activation of protective mechanisms such as
BDNF (Vanhouk & Badding, 2003), CREB (Hardingham et al., 2003), and ERK (Ivanov
et al., 2009). Therefore, activation of these receptors could worsen damage by inhibiting
the cells naturally occurring repair mechanisms. The pyramidal cells of the CA1 express
a high density of NR2B subunits as compared to the CA3 and DG (Butler et al., 2010).
Additionally, this subregion has a greater density of mature neurons and greater
expression of NMDA receptors (Butler et al., 2010). It is therefore not surprising that, as
hypothesized, this subregion also incurred the greatest NMDA induced damage as
compared to the CA3 and DG. Importantly, the pyramidal cells of the CA1 project to
cortical regions of the brain and are crucial to learning and the formation of memory. It
is therefore understandable that those neurodegenerative disorders associated with
excitotoxicity are also associated with memory dysfunction.
Given the central role of the NMDA receptor to the current research, it was
important to demonstrate that the treatment effects observed could be attributed to
activation of this receptor and not due to generalized activity. This was achieved by coexposing cultures to APV and NMDA, which effectively reduced excitotoxicity to
control values (as measured by PI and NeuN) at all time points investigated. Therefore, it
can be said that damage related to the NMDA treatment was mediated selectively by the
NMDA receptor. Previously stated hypotheses indicated that NMDA treatment would
have significant effects on day one and greatest effects on day five (NeuN and NR2B).
PI fluorescence was predicted to be greatest on day one and to decline by day five, as the
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signal was degraded. This occurrence would imply that, upon excitotoxic stimulation of
the NMDA receptor, a mass damage was affected, which destroyed the cell soma,
membrane, and dendrites all following a 24 hour time lapse and escalate uniformly until
day five. However, this did not occur. The greatest membrane damage (PI) was observed
on day one, consistent with the hypothesis. This loss was maintained through day three,
and did not decline back to raw control values (data not shown) until day five. Declines
in the density of mature neurons were significant on day one and peaked on day three,
which was not hypothesized. It was the pattern of NR2B subunit protein loss that was
quite different than expected.

Decreases in these protein levels did not vary from

controls until day three and did not significantly vary on day five. Together, these results
imply that damage begins in the soma, where neuronal markers were affected by NMDA
exposure first. This damage then cascades to affect NR2B protein density in the distal
projections of the neuron, the dendrites.

These effects are elucidated in the visual

timeline provided in Figure 8.
The most likely reason for NR2B protein loss can be explained by a
compensatory down regulation and subsequent reabsorption of the subunit protein. In
response to excessive influxes of Ca2+, the cell would attempt to regain homeostasis by
internalizing and reabsorbing the receptor proteins, thus limiting the influx of the cation.
It is important to note that, because the cell membrane is permeabilized prior to
immunohistochemistry, NR2B staining in these experiments represents both surface
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Figure 7: Visual timeline. Representative images of control and 20µM NMDA exposed
hippocampal slices during days one and five on NeuN immunofluorescence, PI
fluorescence, and NR2B immunofluorescence.
receptors as well as those that are intact but that have been internalized. Therefore,
reductions seen in the NR2B marker would represent a total loss of the protein. Research
conducted in cortical neurons by Bretin et al.(2002), found that transient exposure to 50
μM concentration of NMDA led to decreases in NR2B surface receptors but not total
receptor density. To obtain a loss in total receptor density, 200 μM concentrations of
NMDA were necessary. Importantly, this receptor trafficking was mediated by the
enzyme calpain, which is dependent upon increased levels of intracellular Ca2+
concentrations for activation.

Although the concentration of NMDA necessary to

decrease NR2B proteins in the Bretin et al.(2006), data is 10 times that used in the current
research, exposure time was measure in seconds, whereas tissue in the current research
was exposed for days. Therefore, it is feasible that lengthening exposure time would
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produce increases in Ca2+ concentrations sufficient to activate calpain, leading to the
down regulation and reabsorption of NR2B subunit proteins observed. Calpain activation
is most often associated with detrimental effects resulting from excitotoxicity due to is
capacity to perpetuate increased intracellular Ca2+ concentrations by disrupting the
mechanisms crucial in the maintenance of Ca2+ homeostasis.

For example, known

substrates for calpain include the PMCA transporter and Na+/Ca2+ exchanger.

As

discussed previously, these plasma membrane proteins work to transport Ca2+ from the
cytosol. Once activated, calpain is able to degrade these proteins, leaving the cell without
a high or low affinity Ca2+ transporter (Magnusson et. al., 1993). Additional substrates
for calpain include, the IP3 and ryanodine receptors, both act to sequester Ca2+ in the ER;
degradation of these receptors terminate their ability to function. The protective and
deleterious activity of calpain elucidates the complexity and diversity of enzymes and
signaling molecules activated in response to excitotoxic insult. Beneficially, however,
this complexity offers several opportunities for intervention before cell death becomes
inevitable.
These data indicate the search for such opportunities to block cell death
mechanisms should focus on the soma. The ER and mitochondria, which are resident in
the soma, are likely candidates for such research. Under physiological conditions, the ER
maintains high Ca2+ concentrations within its membrane and expresses two Ca2+
mediating receptors, the IP3 and ryanodine receptors. The IP3 receptor is activated by
IP3, which is bound intracellularly to the plasma membrane and is co-localized with
mGluRs. When mGluRs are activated by extracellular glutamate, IP3 is released from the
plasma membrane and is then free to migrate to the ER membrane. There, it can bind to
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and activate IP3 receptors, changing ER membrane permeability to Ca2+, which will give
rise to cytosolic Ca2+ levels. The ryanodine receptor, also located on the ER membrane,
is activated by cytosolic Ca2+. Therefore, increases in local cytosolic Ca2+ provided by
activation of IP3 receptors can also provide the ligand for ryanodine receptor activation,
leading to a further release of ER sequestered Ca2+. These increased cytosolic levels of
Ca2+ additively affect an already excitotoxic environment.

Similar to the ER,

mitochondria also sequester cytosolic Ca2+. This is done in response to elevated cytosolic
Ca2+ concentrations. However, during excitotoxic conditions when mitochondrial Ca2+
accumulation is prolonged, the mitochondria membrane becomes depolarized and mPTPs
can form; conditions that will release Ca2+ stores and destroy the organelle. In addition to
releasing Ca2+ stores and further elevating cytosolic Ca2+ levels, compromise of the
mitochondrial membrane can also lead to the release of membrane bound cytochrome c
and AIF, both are initiators of apoptosis. It is possible that, by blocking the IP3 receptor
on the ER membrane, the Ca2+ mediated Ca2+ release that would normally follow could
be prevented. This could halt or slow the activation of death pathways, reducing overall
neurodegeneration.
It is important to note that, as these data have been presented thus far, they
represent one of several possible interpretations.

Additionally, there has been no

discussion of limitations concerning the methods employed during these experiments.
As these aspects are important to all research, limitations and alternate interpretations
regarding the current research project will follow.
One limitation in methodology concerns the PI marker. As explained previously,
PI binds to nucleic acids. However, upon excitotoxic insult, glia cells can become
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damaged and can expose nucleic acids to which PI can bind. The resulting PI signal is
therefore increased from what would be evidenced from neuronal injury alone.
Importantly, NeuN, the marker for mature neurons, is specific to neuronal cells. Because
both markers are represented and additionally, tell the same story regarding excitotoxic
damage, the increased fluorescence provided by glial contents is not believed to
significantly affect the data. A second issue regarding the methods concerns the age of
the animals used in this study. Because the rats are PND 8, there are certain limitations
concerning the translation of data. It is important to understand that the organotypic
hippocampal model is just that, a model. By definition, models are representative and
data derived from them should be translated with this fact in mind. While it is likely that
the mechanisms behind excitotoxicity are similar in early development and maturity,
there are cellular molecules whose expression changes with age. For example, calapain 1
expression increases during develop in the rat CNS (Li, et al., 2009). Because this
enzyme is implicated in mediating events associated with excitotoxicity, knowledge of
how its expression changes during development is important when interpreting and
translating data to more developed systems.
The method of organotypic hippocampal slice culture provides researchers many
benefits including the ability to mirror in vivo circuitry.

However, an important

limitation especially pertinent to the current research concerns this circuitry. It has been
shown that over time the CA1 subregion undergoes synaptic reorganization over time and
will develop projections to the DG that are unique to in vitro cultures (Gutiérrez &
Heinemann, 1999). Therefore, the excitotoxicity seen in the CA1 is perhaps increased
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from what would be seen in vivo, as these projections have the ability to confer increased
excitability from the DG to the CA1.
Perhaps the most important caveat to interpreting this data set revolves around
the NR2B subunit. Throughout this document, it has been stated that NR2B subunit
proteins are expressed in the dendrites of the pyramidal cells of the CA1. While this is
true there are also populations found in the membrane of the soma. In the current
interpretation, the decrease of NR2B subunits on day three is said to occur on dendritic
processes. However, it is possible that the declines are occurring in those receptors
populating the soma or declines may be representative of the two locations. However,
because the data show that injury to the neuron begins 24 hours after exposure to NMDA
and this initial injury is occurring in the soma, it is likely that the more distal dendrites
would experience delayed degeneration seen on day three.

Additionally, because

methods used in this study have measured only protein levels, no statement can be made
regarding the functionality of the remaining receptor subunits. To definitively identify
what area is incurring the subunit proteins loss or to investigate the functionality of the
remaining receptors will require subsequent investigation. These studies could include
staining the cells with MAP-2, which is a marker for proteins that make up the structure
of membranes. This marker would allow the topography of the entire neuron to be
visualized using confocal microscopy. By co-labeling with MAP-2 and NR2B, it would
be evident where on the neuronal membrane loss of the subunit proteins was occurring.
The functionality of the receptors could be investigated using Calcium Orange. This
marker carries a fluorescent tag that is activated once it passes into the membrane of a
cell. By comparing Calcium Orange fluorescent values between control and NMDA
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exposed slices, NMDA receptor activity could be determined, although it would not be
selective for NR2B containing receptors.
In conclusion, the current research provides a temporal and topographical map of
the progression of excitotoxic neurodegeneration. The data reveal that initial injury is
evident in the soma. However, even after the occurrence of this significant damage,
distal regions of the cell are still engaging regulatory mechanisms in an effort to stop the
excitatory signal. This information could aid future research in developing therapies to
diminish neurodegeneration resulting from excitotoxicity.
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